Tech Company Inital Public Offerings
SI-BONE IPO
Operating out of Santa Clara, SI-BONE is now a public company.
Transaction Overview
Company Name
Announced On
10/16/2018
Transaction Type
IPO
Amount
$108,000,000
Proceeds Purpose
We expect to use approximately $65.0 million of the net proceeds for sales and marketing activities to support ongoing commercialization of the iFuse Implant System and the remainder, if any, for working capital and general corporate purposes, including research and development and clinical studies.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
471 El Camino Real 101
Santa Clara, CA 95050
USA
Santa Clara, CA 95050
USA
Phone
Website
Email Address
Overview
SI-BONE (Nasdaq: SIBN) is committed to providing high-quality innovative medical devices for the treatment of SI Joint dysfunction. SI-BONE is a leader in the diagnosis and treatment of SI Joint dysfunction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Dunn
Chief Financial Officer
Laura Francis
Chief Technical Officer
Scott Yerby
Founder
Mark Reiley
VP - General Counsel
Michael Pisetsky
VP - Marketing
Joseph Powers
VP - Operations
Andrea Mercanti
VP - Regulatory Affairs
Roxanne Dubois
Browse more venture capital transactions:
Prev: 10/16/2018: PERQ venture capital transaction
Next: 10/16/2018: Berkeley Lights venture capital transaction
Share this article
About Database of VC Transactions
We report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs